These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30854752)

  • 21. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
    Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
    Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.
    Watanabe R; Tabayashi T; Tomikawa T; Sagawa M; Anan-Nemoto T; Kimura Y; Takahashi Y; Tokuhira M; Otaki S; Oi H; Sawano M; Sugiyama S; Kizaki M
    Int J Hematol; 2017 Jan; 105(1):100-103. PubMed ID: 27709451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration.
    Arumugaswamy A; He S; Quach H; Brotchie J; Grigg A
    Intern Med J; 2014 May; 44(5):519-21. PubMed ID: 24816314
    [No Abstract]   [Full Text] [Related]  

  • 24. New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients.
    Yoon JS; Lee YJ; Baek DW; Park HY; Park BE; Moon JH; Sohn SK
    Korean J Intern Med; 2018 Mar; 33(2):435-437. PubMed ID: 26947025
    [No Abstract]   [Full Text] [Related]  

  • 25. [Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP].
    Mori M; Kato M; Koh K; Hanada R
    Rinsho Ketsueki; 2015 May; 56(5):511-3. PubMed ID: 26062675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of thrombopoietin receptor agonists].
    Miyakawa Y
    Rinsho Ketsueki; 2009 Oct; 50(10):1434-43. PubMed ID: 19915352
    [No Abstract]   [Full Text] [Related]  

  • 27. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim.
    Deuson R; Danese M; Mathias SD; Schoonen M; Fryzek J
    J Med Econ; 2012; 15(5):956-76. PubMed ID: 22533524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological and clinical profile of romiplostim (Romiplate(®) 250 µg for s.c. injection)].
    Furuya Y; Ishii H; Aono Y; Arai Y; Onda F; Hasegawa K; Yanagida M
    Nihon Yakurigaku Zasshi; 2011 Jul; 138(1):34-9. PubMed ID: 21747207
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain].
    López MF; Mingot ME; Valcárcel D; Vicente García V; Perrin A; Campos Tapias I
    Med Clin (Barc); 2015 May; 144(9):389-96. PubMed ID: 24565604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful management of primary immune thrombocytopenia with romiplostim during open heart surgery in a hemodialysis patient].
    Nishikii H; Kurita N; Kusakabe M; Yokoyama Y; Kato T; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Rinsho Ketsueki; 2019; 60(1):28-32. PubMed ID: 30726820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of concomitant treatment with romiplostim and warfarin in a patient with immune thrombocytopenia and severe cardiac comorbidities.
    Baldini S; Rigacci L; Carrai V; Fjerza R; Alterini R; Bosi A
    Platelets; 2013; 24(3):242-3. PubMed ID: 22646237
    [No Abstract]   [Full Text] [Related]  

  • 33. [Trombopag for chronic immune thrombocytopenia in a patient previously treated with romiplostim].
    Rodríguez Vargas B; Serna Pérez J; Bermejo Vicedo T
    Farm Hosp; 2013; 37(3):265-6. PubMed ID: 23789804
    [No Abstract]   [Full Text] [Related]  

  • 34. [New therapeutic agents in immunologic idiopathic thrombocytopenic purpura treatment: thrombopoietin receptor agonists].
    Khellaf M
    Rev Med Interne; 2009 Oct; 30(9 Suppl):13-5. PubMed ID: 19874983
    [No Abstract]   [Full Text] [Related]  

  • 35. High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia.
    Seidel MG; Urban C; Sipurzynski J; Beham-Schmid C; Lackner H; Benesch M
    Br J Haematol; 2014 May; 165(3):419-21. PubMed ID: 24484542
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study].
    Weber E; Moulis G; Mahévas M; Guy C; Lioger B; Durieu I; Hunault M; Ramanantsoa M; Royer B; Default A; Pérault-Pochat MC; Moachon L; Bernard N; Bardy G; Jonville-Bera AP; Geniaux H; Godeau B; Cathébras P
    Rev Med Interne; 2017 Mar; 38(3):167-175. PubMed ID: 27793553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres.
    Lakhwani S; Perera M; Fernández-Fuertes F; Ríos de Paz MA; Torres M; Raya JM; Hernández MT
    Eur J Haematol; 2017 Oct; 99(4):372-377. PubMed ID: 28759125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombopoiesis: new ITP paradigm?
    Despotovic JM; Ware RE
    Blood; 2011 Jul; 118(1):1-2. PubMed ID: 21737604
    [No Abstract]   [Full Text] [Related]  

  • 39. Pseudothrombocytopenia in a patient receiving romiplostim for immune thrombocytopenic purpura.
    Fozza C; Pardini S; Marras T; Longu F; Isoni A; Contini S; Longinotti M
    Ann Hematol; 2014 May; 93(5):899-900. PubMed ID: 24081576
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim.
    Al-Samkari H; Van Cott EM; Kuter DJ
    Ann Hematol; 2019 Mar; 98(3):581-588. PubMed ID: 30446804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.